Delivery Order SPE2DB22D1103-SPE2DB24FTCM7
- Not listed
- This is a federal contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of 4,567,878,956 units of Cetirizine HCL 10 mg tablets. The contract has a ceiling value of $5,295.54 and runs through April 14, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a...
- This federal contract award, valued at $4,702.71, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,073,284 units of Cetirizine HCL 10 mg tablets, a prescription medication, with a completion date of April 30, 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp...
- This federal contract award, valued at $2,051.14, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of 4,566,674,952 units of Cetirizine HCL 10 mg tablets, a pharmaceutical product used for various medical purposes. The contract has a completion date of December 11, 2024 and utilizes a firm fixed-price pricing structure. It is not designated as a set-aside contract. Amerisourcebergen Drug Corp is a major...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The Delivery Order contract, valued at $1,188.32, is for the supply of Cetirizine HCL 5 mg Tablets in 100-count packages. The contract has an ultimate completion date of October 17, 2023, and is a Firm Fixed Price type. Amerisourcebergen Drug Corp is a subsidiary of the parent company, Cencora, Inc., which is a...
- This is a federal contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,083.88 Firm Fixed Price delivery order contract is for the supply of 10 mg Cetirizine HCL tablets. The contract has an ultimate completion date of June 9, 2025 and is not set aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $37,680.23, is for the delivery of 4,567,781,423 units of Cetirizine HCL 10 mg tablets. The contract is a delivery order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,197.91 firm-fixed-price delivery order is for the supply of 4,562,549,817 units of Cetirizine HCL 5 mg tablets. The contract has an ultimate completion date of October 23, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, was issued by the Defense Logistics Agency (DLA) for the delivery of 4,562,926,968 tablets of the drug Cetirizine HCl 5 mg. The contract has a firm fixed price of $12,461.65 and a completion date of November 29, 2023. This award is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA...
- This federal contract award, with ID SPE2DB20D1004 and SPE2DB23FG5G5, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4,562,101,806 units of Cetirizine HCL 10 mg tablets, a generic pharmaceutical product. The total ceiling value of the contract is $1,570.36, with a firm fixed-price pricing type. The contract has an ultimate completion date of September 11, 2023 and was...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $63,512.75, is for the delivery of 4,563,866,824 units of the drug Cetirizine HCL 5 mg tablets in 100-count bottles. The contract is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at $999,999,999 and running through...
- SPE2DB22D1103Indefinite Delivery Contract
- SPE2DB22D1103-SPE2DB24FTCM7Delivery Order
This federal contract award, with a ceiling value of $3,543.80, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is a delivery order (SPE2DB22D1103|SPE2DB24FTCM7) for the supply of 4,563,043,076 units of Cetirizine HCL 5 mg tablets, a generic pharmaceutical product. The contract has an ultimate completion date of December 11, 2023 and uses a firm fixed price pricing type. This contract is not designated as a set-aside. Amerisourcebergen is a major pharmaceutical distributor and healthcare solutions provider that has a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, to supply a wide range of pharmaceutical products and medical supplies to support military and veterans' healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.5k | 12/8/23 |